Document is current
Any future updates will be listed below
-
Authors
Reza, Tania F.
Nalugwa, Talemwa
Farr, Katherine
Nantale, Mariam
Oyuku, Denis
Nakaweesa, Annet
Musinguzi, Johnson
Vangala, Moksha
Shete, Priya B.
Tucker, Austin
Ferguson, Olivia
Fielding, Katherine
Sohn, Hojoon
Dowdy, David
Moore, David A. J.
Davis, J. Lucian
Ackerman, Sara L.
Handley, Margaret A.
Katamba, Achilles
Cattamanchi, Adithya
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (5R01HL130192)
- License Information
-
More Information
Article History
Received: 17 March 2020
Accepted: 3 April 2020
First Online: 21 April 2020
Ethics approval and consent to participate
: The trial was approved by the institutional review boards at the University of California San Francisco (approval number: 17-21505), Makerere University College of Health Sciences (HDREC 595), and the Uganda National Council for Science and Technology (HS 2437). It is registered with the US National Institutes of Health’s (identifier: NCT03044158) and the Pan African Clinical Trials Registry (identifier: PACTR201610001763265) as a phase 4 clinical trial.
: Not applicable
: The authors declare no competing interests.
